{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:02:10Z","timestamp":1791241330772,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T00:00:00Z","timestamp":1311206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/gene.2011.42","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T05:05:39Z","timestamp":1311224739000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Epstein-Barr virus and multiple sclerosis: interaction with HLA"],"prefix":"10.1038","volume":"13","author":[{"given":"E","family":"Sundqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Hedstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Kockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,21]]},"reference":[{"key":"BFgene201142_CR1","doi-asserted-by":"publisher","first-page":"e664","DOI":"10.1371\/journal.pone.0000664","volume":"2","author":"B Brynedal","year":"2007","unstructured":"Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2007; 2: e664.","journal-title":"PLoS One"},{"key":"BFgene201142_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrneurol.2010.1","volume":"6","author":"AE Handel","year":"2010","unstructured":"Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV . Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010; 6: 156\u2013166.","journal-title":"Nat Rev Neurol"},{"key":"BFgene201142_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/jnnp.29.1.60","volume":"29","author":"U Leibowitz","year":"1966","unstructured":"Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M . Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966; 29: 60\u201368.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFgene201142_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL . Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61: 288\u2013299.","journal-title":"Ann Neurol"},{"key":"BFgene201142_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.55.2.164","volume":"55","author":"SF Hunter","year":"2000","unstructured":"Hunter SF, Hafler DA . Ubiquitous pathogens: Links between infection and autoimmunity in MS? Neurology 2000; 55: 164\u2013165.","journal-title":"Neurology"},{"key":"BFgene201142_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","volume":"5","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL . Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010; 5: 271\u2013277.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFgene201142_CR7","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001; 286: 3083\u20133088.","journal-title":"JAMA"},{"key":"BFgene201142_CR8","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","volume":"62","author":"P Sundstrom","year":"2004","unstructured":"Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62: 2277\u20132282.","journal-title":"Neurology"},{"key":"BFgene201142_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.08.004","volume":"215","author":"P Sundstrom","year":"2009","unstructured":"Sundstrom P, Nystrom M, Ruuth K, Lundgren E . Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis. J Neuroimmunol 2009; 215: 102\u2013107.","journal-title":"J Neuroimmunol"},{"key":"BFgene201142_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00001648-199209000-00012","volume":"3","author":"DW Hosmer","year":"1992","unstructured":"Hosmer DW, Lemeshow S . Confidence interval estimation of interaction. Epidemiology 1992; 3: 452\u2013456.","journal-title":"Epidemiology"},{"key":"BFgene201142_CR11","volume-title":"Epidemiology: An Introduction","author":"KJ Rothman","year":"2002","unstructured":"Rothman KJ . Epidemiology: An Introduction. Oxford University Press: New York, NY, 2002, viii, 223pp."},{"key":"BFgene201142_CR12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1177\/1352458508092353","volume":"14","author":"P Sundstrom","year":"2008","unstructured":"Sundstrom P, Nystrom L, Jidell E, Hallmans G . EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Mult Scler 2008; 14: 1120\u20131122.","journal-title":"Mult Scler"},{"issue":"Pt 2","key":"BFgene201142_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL De Jager","year":"2008","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A . Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008; 70 (Pt 2): 1113\u20131118.","journal-title":"Neurology"},{"key":"BFgene201142_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1352458508100037","volume":"15","author":"TR Nielsen","year":"2009","unstructured":"Nielsen TR, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler 2009; 15: 431\u2013436.","journal-title":"Mult Scler"},{"key":"BFgene201142_CR15","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/WNL.0b013e3181dad57e","volume":"74","author":"KC Simon","year":"2010","unstructured":"Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T et al. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 2010; 74: 1365\u20131371.","journal-title":"Neurology"},{"key":"BFgene201142_CR16","doi-asserted-by":"publisher","first-page":"e4565","DOI":"10.1371\/journal.pone.0004565","volume":"4","author":"DS Goodin","year":"2009","unstructured":"Goodin DS . The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 2009; 4: e4565.","journal-title":"PLoS One"},{"key":"BFgene201142_CR17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ana.21978","volume":"67","author":"LI Levin","year":"2010","unstructured":"Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A . Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010; 67: 824\u2013830.","journal-title":"Ann Neurol"},{"key":"BFgene201142_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.autrev.2009.01.017","volume":"8","author":"MP Pender","year":"2009","unstructured":"Pender MP . Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun Rev 2009; 8: 563\u2013568.","journal-title":"Autoimmun Rev"},{"key":"BFgene201142_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08916930802024772","volume":"41","author":"HH Niller","year":"2008","unstructured":"Niller HH, Wolf H, Minarovits J . Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008; 41: 298\u2013328.","journal-title":"Autoimmunity"},{"key":"BFgene201142_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/jnnp.65.1.48","volume":"65","author":"KH Rand","year":"1998","unstructured":"Rand KH, Houck H, Denslow ND, Heilman KM . Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 48\u201355.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFgene201142_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nri2548","volume":"9","author":"L Steinman","year":"2009","unstructured":"Steinman L . A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009; 9: 440\u2013447.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201142_CR22","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1128\/jvi.71.6.4657-4662.1997","volume":"71","author":"Q Li","year":"1997","unstructured":"Li Q, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B et al. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 1997; 71: 4657\u20134662.","journal-title":"J Virol"},{"key":"BFgene201142_CR23","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899\u20132912.","journal-title":"J Exp Med"},{"key":"BFgene201142_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/NEN.0b013e3181e332ec","volume":"69","author":"B Serafini","year":"2010","unstructured":"Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 2010; 69: 677\u2013693.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 12","key":"BFgene201142_CR25","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1093\/brain\/awq223","volume":"133","author":"F Aloisi","year":"2010","unstructured":"Aloisi F, Serafini B, Magliozzi R, Howell OW, Reynolds R . Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain 2010; 133 (Pt 12): e157.","journal-title":"Brain"},{"key":"BFgene201142_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","volume":"230","author":"C Casiraghi","year":"2011","unstructured":"Casiraghi C, Dorovini-Zis K, Horwitz MS . Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol 2011; 230: 173\u2013177.","journal-title":"J Neuroimmunol"},{"key":"BFgene201142_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2009.01.023","volume":"209","author":"R Zivadinov","year":"2009","unstructured":"Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A et al. Gene-environment interactions between HLA B7\/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. J Neuroimmunol 2009; 209: 123\u2013130.","journal-title":"J Neuroimmunol"},{"key":"BFgene201142_CR28","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI32377","volume":"117","author":"KA McAulay","year":"2007","unstructured":"McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL et al. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117: 3042\u20133048.","journal-title":"J Clin Invest"},{"key":"BFgene201142_CR29","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1073\/pnas.0915054107","volume":"107","author":"H Hjalgrim","year":"2010","unstructured":"Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA 2010; 107: 6400\u20136405.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgene201142_CR30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan JL . Infectious mononucleosis. N Engl J Med 2010; 362: 1993\u20132000.","journal-title":"N Engl J Med"},{"key":"BFgene201142_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1212\/WNL.0b013e3181b59c40","volume":"73","author":"AK Hedstrom","year":"2009","unstructured":"Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L . Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009; 73: 696\u2013701.","journal-title":"Neurology"},{"key":"BFgene201142_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/WCO.0b013e32832b5417","volume":"22","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan SV, Knight JC, Ebers GC . Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009; 22: 219\u2013225.","journal-title":"Curr Opin Neurol"},{"key":"BFgene201142_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","volume":"39","author":"O Olerup","year":"1992","unstructured":"Olerup O, Zetterquist H . HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225\u2013235.","journal-title":"Tissue Antigens"},{"key":"BFgene201142_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","volume":"20","author":"T Andersson","year":"2005","unstructured":"Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A . Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575\u2013579.","journal-title":"Eur J Epidemiol"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T18:47:08Z","timestamp":1712602028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFgene201142"],"URL":"https:\/\/doi.org\/10.1038\/gene.2011.42","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,21]]},"assertion":[{"value":"23 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ms Sundqvist has received research support from the Swedish Association for Persons with Neurological Disabilities. Professor Hillert has received unrestricted research support from BiogenIdec, MerckSerono and Bayer Schering. Professor Alfredsson receives research support from the Swedish Medical Research Council (Dnr 521-2009-2596) and Swedish Council for Working life and Social Research (Dnr 2009-0650). Professor Tomas Olsson has received grant support for MS research from unrestricted grant support from BiogenIdec, Bayer, SanofiAventis and Merck, and also lecture fees and\/or advisory board consultancies for the same companies. Other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}